Parker AL - Search Results

1

Respiratory muscle strength training with nonrespiratory maneuvers.

DePalo VA, Parker AL, Al-Bilbeisi F, McCool FD. DePalo VA, et al. Among authors: al bilbeisi f, parker al. J Appl Physiol (1985). 2004 Feb;96(2):731-4. doi: 10.1152/japplphysiol.00511.2003. Epub 2003 Sep 26. J Appl Physiol (1985). 2004. PMID: 14514702

2

Respiratory system mechanics in a patient with massive subcutaneous emphysema.

Parker AL, McCool FD. Parker AL, et al. Med Health R I. 2001 Nov;84(11):369-71. Med Health R I. 2001. PMID: 12355665 No abstract available.

3

Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction.

Parker AL. Parker AL. J Asthma. 2004 Sep;41(6):671-7. doi: 10.1081/jas-200026438. J Asthma. 2004. PMID: 15584317

4

Pulmonary function characteristics in patients with different patterns of methacholine airway hyperresponsiveness.

Parker AL, McCool FD. Parker AL, et al. Chest. 2002 Jun;121(6):1818-23. doi: 10.1378/chest.121.6.1818. Chest. 2002. PMID: 12065344

5

Aging does not affect beta-agonist responsiveness after methacholine-induced bronchoconstriction.

Parker AL. Parker AL. J Am Geriatr Soc. 2004 Mar;52(3):388-92. doi: 10.1111/j.1532-5415.2004.52110.x. J Am Geriatr Soc. 2004. PMID: 14962153

6

Ratio between forced expiratory flow between 25% and 75% of vital capacity and FVC is a determinant of airway reactivity and sensitivity to methacholine.

Parker AL, Abu-Hijleh M, McCool FD. Parker AL, et al. Chest. 2003 Jul;124(1):63-9. doi: 10.1378/chest.124.1.63. Chest. 2003. PMID: 12853503

7

Clinical variables are poor selection criteria for the use of methacholine bronchoprovocation in symptomatic subjects.

Parker AL, Abu-Hijleh M. Parker AL, et al. Respir Care. 2003 Jun;48(6):596-601. Respir Care. 2003. PMID: 12780946

8

Hemoptysis in sarcoidosis: a case report.

Parker AL, Clarke EM, Rounds S. Parker AL, et al. Med Health R I. 1996 Sep;79(9):328-30. Med Health R I. 1996. PMID: 8885629 No abstract available.

9

Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10.

Bates EA, Davies JA, Váňová J, Nestić D, Meniel VS, Koushyar S, Cunliffe TG, Mundy RM, Moses E, Uusi-Kerttula HK, Baker AT, Cole DK, Majhen D, Rizkallah PJ, Phesse T, Chester JD, Parker AL. Bates EA, et al. Among authors: parker al. Mol Ther Oncolytics. 2022 Mar 16;25:43-56. doi: 10.1016/j.omto.2022.03.007. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35399606 Free PMC article.

10

The aetiopathogenesis of vaccine-induced immune thrombotic thrombocytopenia.

Toh CH, Wang G, Parker AL. Toh CH, et al. Among authors: parker al. Clin Med (Lond). 2022 Mar;22(2):140-144. doi: 10.7861/clinmed.2022-0006. Epub 2022 Mar 10. Clin Med (Lond). 2022. PMID: 35273026 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results